Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 3
MDDGA3

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 3 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Glaucoma nervous 100 % 17030669 2024-05-06
Cerebellum hypoplasia nervous 100 % 17030669 2024-05-06
Hypotonia nervous 100 % 17030669 2024-05-06
Visual impairment nervous 100 % 17030669 2024-05-06
Hypoplastic pons nervous 100 % 17030669 2024-05-06
Frontocortical dysplasia nervous 100 % 17030669 2024-05-06
Cerebellar cysts nervous 67 % 17030669 2024-05-06
Seizures nervous 33 % 17030669 2024-05-02
non-walking multi 33 % 17030669 2024-05-02
White matter hyperintensities nervous 33 % 17030669 2024-05-06
Cataract nervous 33 % 17030669 2024-05-06
Megalocornea nervous 33 % 17030669 2024-05-06
Gait disturbances multi 33 % 17030669 2024-05-06
Myopia nervous 33 % 17030669 2024-05-06



List of references:


POMGnT1 mutations in congenital muscular dystrophy: genotype-phenotype correlation and expanded clinical spectrum.
Roberta Biancheri, Enrico Bertini, Antonio Falace, Marina Pedemonte, Andrea Rossi, Adele D'Amico, Sara Scapolan, Laura Bergamino, Stefania Petrini, Denise Cassandrini, Paolo Broda, Mario Manfredi, Federico Zara, Filippo M Santorelli, Carlo Minetti, Claudio Bruno,



Archives of neurology - Oct 2006